Company Overview and News
Stop missing out on important events!
PolyNovo Ltd (ASX:PNV) has signed an agreement with Establishment Labs to jointly develop a range of medical devices for use in breast surgery.
Polynovo Ltd (ASX:PNV) has signed a distribution agreement with AMI Medical Technologies in Israel for its NovoSorb™ BTM tissue scaffold used for skin regeneration.
Polynovo Ltd's (ASX:PNV) shares last traded at $0.285, or around 60% higher than a month ago, with the company receiving a positive re-rating following its first U.S. sales of NovoSorb BTM™
PolyNovo (ASX:PNV) is a Melbourne-based regenerative medical device company that designs, develops and manufactures devices using its patented NovoSorb™ biodegradable polymer technology.